NVAX — NOVAVAX INC

—
Nasdaq · Health Care · Biotechnology · CIK 1000694 ·
Last close
$7.96
Market Cap
$1.31B
52W High
$13.39
52W Low
$6.20
ADV30
6,970,439
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 68,298,000 44,810,000 -31,281,000 -31,376,000 888,005,000 222,455,000 1,104,860,000
Jun 2026 56,698,000 42,452,000 -54,906,000 -53,387,000 955,575,000 191,458,000 1,146,282,000
Mar 2026 139,514,000 108,819,000 -15,430,000 -9,491,000 1,043,162,000 228,363,000 1,187,924,000
Dec 2025 147,139,000 125,035,000 15,037,000 17,527,000 1,176,512,000 240,634,000 1,304,265,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-36,901,000
Investing CF
$-109,510,000
Financing CF
$74,714,000
CapEx
$-6,124,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.52
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-4,631,026,000
Inventory
$10,006,000
Receivables
$18,739,000
ST Investments
$527,882,000
EBIT TTM
$-223,419,000
Pretax Income TTM
$-245,315,000
Interest Exp TTM
$21,896,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$411,648,992
EBITDA
$-55,594,000
Free Cash Flow
$11,756,062
Enterprise Value
$1,451,697,152
Total Cash
$622,363,008
Total Debt
$295,263,008
Shares Out
165,009,009
Trailing EPS
$-0.52
Book Value
$-1.31
ROE
—
ROA
-4.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,123,479,000 550,640,000 440,302,000 1,176,512,000 1,304,265,000 -127,753,000 -244,635,000
Dec 2024 682,162,000 -248,931,000 -187,499,000 1,560,418,000 2,184,259,000 -623,841,000 -87,263,000
Dec 2023 556,382,000 -566,511,000 -545,062,000 1,797,490,000 2,514,417,000 -716,927,000 -713,967,000
Dec 2022 1,598,951,000 -644,736,000 -657,939,000 2,258,679,000 2,892,757,000 -634,078,000 -415,937,000

TTM Snapshot

Revenues TTM
$413,796,000
NetIncome TTM
$-247,730,000
OpCashFlow TTM
—
Assets (Latest)
$955,575,000
Forward EPS
$-0.51

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $8.00 · spot: $7.96 · call volume: 3,364 · put volume: 72
Expected Move to 2027-04-16: ±$3.02 (37.94%) — implied range $4.94 – $10.98 · ATM straddle on $8.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
TSHA Taysha Gene Therapies, Inc. $1.30B $4.00 —
IMCR Immunocore Holdings plc $1.43B $27.81 —
MEOBF MESOBLAST LTD $1.48B $1.14 —
VOR Vor Biopharma Inc. $1.12B $18.18 —
MESO MESOBLAST LTD $1.55B $11.91 —

News headlines (Yahoo Finance, 1h cache)

Novavax Eyes New Partnerships as Sanofi Advances COVID-Flu Vaccine Trial
2026-11-17 21:12 · Yahoo
Novavax to Participate in Jefferies London Healthcare Conference
2026-11-11 22:00 · Yahoo
NVAX Q3 2026 deep dive: Sanofi milestone and cost controls shape outlook
2026-11-10 13:01 · Yahoo
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
2026-11-10 13:00 · Yahoo
Novavax (NVAX) stock trades up, here is why
2026-11-10 06:45 · Yahoo
Novavax (NVAX) Looks Cheap After Sanofi Milestone And Stronger Q3 Results
2026-11-07 16:10 · Yahoo
Novavax Q3 Earnings Call Highlights
2026-11-06 10:14 · Yahoo
Novavax Inc (NVAX) (Q3 2026) Earnings Call Highlights: Sanofi Milestone Lifts Revenue Outlook ...
2026-11-06 01:15 · Yahoo
Novavax (NVAX) reports earnings tomorrow: what to expect
2026-11-05 23:41 · Yahoo
Novavax (NVAX) Q3 2026 Earnings Call Transcript
2026-11-05 20:09 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.